Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.51 |
| ▸ | PPARA | Q07869 | 5/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | TERT | O14746 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | PPARD | Q03181 | 3/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | GMNN | O75496 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5452957 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL2342147 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL3710792 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL11743976 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL14672999 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL874683 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL347470 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL22555434 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL22555479 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT | |
| SCHEMBL7902650 | 1.00 | PPARG (0.51) | PPARGPPARACNR1CNR2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12428360-B2 | Abating unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | ECOLAB USA INC. (US) | 2025-09-30 | — | — | US | claimed |
| WO-2025090952-A1 | DESATURASE VARIANTS AND METHODS OF USE | GENOMATICA, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| EP-4504680-A1 | ABATING UNWANTED EMULSION POLYMERIZATION DURING EXTRACTIVE DISTILLATION OF CONJUGATED DIENE MONOMERS | ECOLAB USA INC. (US) | 2025-02-12 | — | — | EP | claimed |
| CN-118901734-A | Attractant for controlling arthropods, preparation method and application method | 中国咖啡工程研究中心 | 2024-11-08 | — | — | CN | claimed |
| US-20240327882-A1 | Methods and Compositions for Increasing Bio-products in Cyanobacteria using Low-Dose Antibiotics | MORGAN STATE UNIVERSITY | 2024-10-03 | — | — | US | claimed |
| US-20240309407-A1 | Composition and Method for Increasing Fatty Acid Production in Cyanobacteria by Altering Cell Membrane Permeability | MORGAN STATE UNIVERSITY | 2024-09-19 | — | — | US | claimed |
| US-20240269320-A1 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | EYEDEA BIO, LLC | 2024-08-15 | — | — | US | claimed |
| EP-4351612-A2 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | Eyedea Bio, Llc (US) | 2024-04-17 | — | — | EP | claimed |
| EP-4347616-A2 | INTRAVITREAL MITOCHONDRIAL-TARGETED PEPTIDE PRODRUGS AND METHODS OF USE | Eyedea Bio, Llc (US) | 2024-04-10 | — | — | EP | claimed |
| US-20230312441-A1 | ABATING UNWANTED EMULSION POLYMERIZATION DURING EXTRACTIVE DISTILLATION OF CONJUGATED DIENE MONOMERS | ECOLAB USA INC. (US) | 2023-10-05 | — | — | US | claimed |
| US-6197731-B1 | PRODUCE LOWER AMOUNTS OF OBSERVABLE SMOKE IN EXHAUST EMITTED AS RESULT OF COMBUSTION IN TWO-CYCLE GASOLINE ENGINE, REQUIRE NO MISCIBILITY-ENHANCING SOLVENTS; BIODEGRADABLE | HENKEL CORPORATION | 2001-03-06 | — | — | US | claimed |
| EP-0946683-A4 | LUBRICANTS FOR DIESEL FUEL | HENKEL CORP (US) | 2001-01-03 | — | — | EP | claimed |
| US-6080212-A | DIESEL FUEL ADDITIVE COMPRISING MIXTURE OF FATTY ESTERS AND OLIGOMERIC ALIPHATIC ESTERS; SMOKELESS EXHAUST | HENKEL CORPORATION (US) | 2000-06-27 | — | — | US | claimed |
| EP-0846152-A4 | SMOKELESS TWO-CYCLE ENGINE LUBRICANTS | HENKEL CORP (US) | 2000-05-03 | — | — | EP | claimed |
| EP-0946683-A1 | LUBRICANTS FOR DIESEL FUEL | HENKEL CORPORATION (US) | 1999-10-06 | — | — | EP | claimed |
| EP-0846152-A2 | SMOKELESS TWO-CYCLE ENGINE LUBRICANTS | HENKEL CORPORATION (US) | 1998-06-10 | — | — | EP | claimed |
| WO-1998021293-A1 | LUBRICANTS FOR DIESEL FUEL | HENKEL CORPORATION (US) | 1998-05-22 | — | — | WO | claimed |
| WO-1997008277-A2 | SMOKELESS TWO-CYCLE ENGINE LUBRICANTS | HENKEL CORPORATION (US) | 1997-03-06 | — | — | WO | claimed |
| US-5536889-A | LIQUID PHASE, CATALYST COMPRISING COPPER, ZINC AND ALUMINUM, ZIRCONIUM, MAGNESIUM OR A RARE EARTH METAL | SHELL OIL COMPANY (US) | 1996-07-16 | — | — | US | claimed |
| US-5475159-A | Using a cata;yst comprising a copper compound, a zinc compound, and at least one compound selected from aluminum, zirconium, magnesium and rare earths | SHELL OIL COMPANY (US) | 1995-12-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12428360-B2 | Abating unwanted emulsion polymerization during extractive distillation of conjugated diene monomers | DDT, PLD1, PNMT | PPARG 2991/4885PPARA 1525/4885CNR1 657/4885 |
| US-20230312441-A1 | ABATING UNWANTED EMULSION POLYMERIZATION DURING EXTRACTIVE DISTILLATION OF CONJUGATED DIENE MONOMERS | DDT, PLD1, PNMT | PPARG 2991/4885PPARA 1525/4885CNR1 657/4885 |
| US-20240269320-A1 | EXTENDED RELEASE DRUG DELIVERY SYSTEM FOR OCULAR DRUGS AND METHODS OF USE | CHMP4B, UACA, VEGFA | PPARG 3769/4885PPARA 3212/4885CNR1 124/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.